The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis

Journal of Molecular Medicine

Volumn 80, Issue 4, 2002, Pages 258-266

  Wernert, Nicolas ^a   Justen, Hans Peter ^b   Rothe, Marcus ^a   Behrens, Peter ^a   Dreschers, Stephan ^a   Neuhaus, Thomas ^c   Florin, Alexandra ^a   Sachinidis, Agapios ^c   Vetter, Hans ^c   Ko, Yon ^c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Arthritis; Ets 1; Immunohistochemistry; In situ hybridization; Real time PCR

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR ETS 1; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEOVASCULARIZATION (PATHOLOGY); OSTEOARTHRITIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OSTEOARTHRITIS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0036240498     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-001-0316-0     Document Type: Article

References (47)

1. Starving the synovium: Angiogenesis and inflammation in rheumatoid arthritis
2. Angiogenesis in rheumatoid arthritis: Pathogenic and clinical significance
3. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin
4. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
5. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: Reduction of vascular endothelial growth factor (VEGF)
6. Angiogenesis inhibition suppresses collagen arthritis
7. Decreased angiogenesis and artritic disease in rabbits treated with an alphavbeta3 antagonist
8. New vessels, new approaches: Angiogenesis as a therapeutic target in musculoskeletal disorders
9. Angiogenesis in cancer, vascular, rheumatoid, and other diseases
10. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen factor system
11. Angiogenesis in cancer and other diseases
12. Vascular-specific growth factors and blood vessel formation
13. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
14. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
15. A cancer therapy resistant to resistance
16. VEGF gene therapy: Stimulating angiogenesis or angioma-genesis?
17. Vascular endothelial growth factor, a potent and selective angiogenic agent
18. Regulation of angiogenesis via vascular endothelial growth factor receptors
19. The multiple roles of tumour stroma
20. The ets gene family
21. Ets transcription factors and human disease
22. Molecular phylogeny of the Ets gene family
23. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood forming system of the chick embryo
24. The c-ets 1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in man
25. Stromal expression of c-Ets 1 transcription factor correlates with tumor invasion
26. Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis
27. The codependence of angiogenesis and chronic inflammation
28. Localization of vascular endothelial growth factor in synovial membrane mast cells: Examination with "multi-labelling subtraction immunostaining"
29. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts
30. Inhibition of in-vivo angiogenesis by ets-1 antisense oligonucleotides - Inhibition of Ets-1 transcription factor expression by the antibiotic fumagillin
31. Ets 1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
32. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
33. Reverse transcriptase-polymerase chain reaction (RT-PCR): A sensitive method to examine basic fibroblast growth factor-induced expression of the early growth response gene-1 (egr-1) in human umbilical arterial endothelial cells
34. An extended table of critical values for the Mann-Whitney (Wilcoxon) two sample statistic
35. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay
36. Competitive reverse transcription/polymerase chain reaction for the quantification of p53 and mdm2 mRNA expression
37. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis
38. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis
39. The matrix matalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient
40. Matrix metalloproteinase-19 in capillary endothelial cells: Expression in acutely, but not in chronically, inflamed synovium
41. The c-ets protooncogenes encode transcription factors that cooperate with c-fos and c-jun for transcriptional activation
42. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′ flanking region
43. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity
44. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction
45. Possible background mechanisms of the effectiveness of cyclooxygenase-2 inhibitor in the treatment of rheumatoid arthritis
46. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor
47. Tempe (fermented soybeans) isoflavonoids and tempe extract downregulate the angiogenesis and invasion-related stromal Ets 1 transcription factor in cultured human endothelial cells and fibroblasts